Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend

May 30, 2013

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend, one of Norway’s largest veterinary clinics. A joint project is planned for the construction of a new veterinary hospital in Bergen. Djursjukhusgruppen is the Nordic region’s leading group of companies providing advanced veterinary care for dogs, cats and other pets.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alexandra Kempe, Magnus Wieslander and Gustav Jönsson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025